Problem

Metofico addresses a data-analysis bottleneck in preclinical and life-science research. Modern techniques produce datasets that are too large and complex for traditional tools such as Excel, while available analysis software may be missing, unsuitable, or dependent on coding and advanced data-science skills. The economic pain is primarily researcher time and lost scientific opportunity: analyses that can consume weeks or months delay experiments and may cause researchers to miss insights.

The clearest use case is data-intensive preclinical neuroscience, particularly rodent video tracking and fiber-photometry analysis. These workflows combine large behavioral or brain-activity datasets with specialized processing requirements, making them difficult for researchers without programming expertise to analyze efficiently.

Product / Service

Metofico offers an intuitive, no-code SaaS product delivered through an all-in-one online platform with modules for different types of preclinical data analysis. Its TOMB-AI product automatically scores behavior directly from video without preprocessing, keypoint annotation, or polygon detection, and can track multiple subjects in the same setup. Its Fiber Photometry Analyzer supports up to four light channels per animal and provides tools for organizing animals, groups, subgroups, and events.

The intended benefit is to convert complex analysis workflows that previously took weeks or months into processes achievable in minutes, without requiring programming knowledge. The company uses a software-led evaluation model that includes free demos and trials, allowing researchers to test the tools against their own research goals.

Market

Metofico competes in life-science and preclinical research data-analysis software, particularly the emerging no-code SaaS segment serving neuroscience, behavioral tracking, photometry, and related workflows. The market appears fragmented across specialized tools: FiPhA is an open-source interface for analyzing behavioral and fiber-photometry data, DORIC's danseTM is a no-coding fiber-photometry and behavioral-data tool, and Imalytics Preclinical addresses biomedical-image segmentation, reconstruction, visualization, and analysis. These are best viewed as adjacent or workflow-specific alternatives rather than evidence of a single comprehensive direct competitor.

The available evidence indicates an early but active company rather than a scaled software business. Metofico was founded in 2021, joined Y Combinator's Winter 2024 batch, and is listed by YC as an active SaaS company with a two-person team. It has launched TOMB-AI, received a 2026 Science new-products mention, and lists research-publication exposure including Nature Metabolism. However, the evidence does not disclose customer counts, revenue, or user metrics, so it cannot establish that Metofico is pre-revenue; the most supportable characterization is an early-stage company with product-launch and pilot-oriented traction.